Robotic-assisted laparoscopic surgery—most rapidly in urology but also in gynaecology, cardiothoracics, head and neck, and general surgery has fascinated surgeons. But has this innovation in surgery translated to benefits for patients? The Da Vinci surgical system is the only robot approved by the FDA for soft tissue surgery. The device provides a magnified 3D view of the operative field from a console, from which the surgeon controls the robot which holds a camera and tremor-free instruments with a greater range of movement than laparoscopic instruments.The benefits to the surgeon are fantastic. There is improved vision and precision. Robotic surgery is more expensive than open surgery due to the cost of the robot (an initial outlay of some £1•5 million) and disposable equipment but this may be offset by other savings, such as reduced length of stay or reduction in complications. Start-up costs are high. Which procedure in your opinion has better outcomes: robotic or open or laparoscopic surgery?